# A Phase I Study of Famitinib Malate in Patients With Solid Tumor

> **NCT01762280** · PHASE1 · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 55 (actual)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** Famitinib Malate Capsule

## Key facts

- **NCT ID:** NCT01762280
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2012-04
- **Final completion:** 2012-07
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2018-04-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01762280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01762280, "A Phase I Study of Famitinib Malate in Patients With Solid Tumor". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01762280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*